TY - JOUR
T1 - Eczema prevalence in the United States
T2 - Data from the 2003 national survey of children's health
AU - Shaw, Tatyana E.
AU - Currie, Gabriel P.
AU - Koudelka, Caroline W.
AU - Simpson, Eric L.
N1 - Funding Information:
We thank the Child and Adolescent Health Measurement Initiative (CAHMI) at the Oregon Health and Science University for providing the data set ( http://www.cahmi.org ). This publication was made possible with support from the Oregon Clinical and Translational Research Institute (OCTRI), grant number UL1 RR024140 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. We also thank Christine E. Carocci for assistance with proofreading, editing, and preparation of this paper. This work was performed in Portland, Oregon, USA.
PY - 2011/1
Y1 - 2011/1
N2 - Using the 2003 National Survey of Children's Health sponsored by the federal Maternal and Child Health Bureau, we calculated prevalence estimates of eczema nationally and for each state among a nationally representative sample of 102,353 children 17 years of age and under. Our objective was to determine the national prevalence of eczema/atopic dermatitis in the US pediatric population and to further examine geographic and demographic associations previously reported in other countries. Overall, 10.7% of children were reported to have a diagnosis of eczema in the past 12 months. Prevalence ranged from 8.7 to 18.1% between states and districts, with the highest prevalence reported in many of the East Coast states, as well as in Nevada, Utah, and Idaho. After adjusting for confounders, metropolitan living was found to be a significant factor in predicting a higher disease prevalence with an odds ratio of 1.67 (95% confidence interval of 1.19-2.35, P=0.008). Black race (odds ratio 1.70, P=0.005) and education level in the household greater than high school (odds ratio 1.61, P=0.004) were also significantly associated with a higher prevalence of eczema. The wide range of prevalence suggests that social or environmental factors may influence disease expression.
AB - Using the 2003 National Survey of Children's Health sponsored by the federal Maternal and Child Health Bureau, we calculated prevalence estimates of eczema nationally and for each state among a nationally representative sample of 102,353 children 17 years of age and under. Our objective was to determine the national prevalence of eczema/atopic dermatitis in the US pediatric population and to further examine geographic and demographic associations previously reported in other countries. Overall, 10.7% of children were reported to have a diagnosis of eczema in the past 12 months. Prevalence ranged from 8.7 to 18.1% between states and districts, with the highest prevalence reported in many of the East Coast states, as well as in Nevada, Utah, and Idaho. After adjusting for confounders, metropolitan living was found to be a significant factor in predicting a higher disease prevalence with an odds ratio of 1.67 (95% confidence interval of 1.19-2.35, P=0.008). Black race (odds ratio 1.70, P=0.005) and education level in the household greater than high school (odds ratio 1.61, P=0.004) were also significantly associated with a higher prevalence of eczema. The wide range of prevalence suggests that social or environmental factors may influence disease expression.
UR - http://www.scopus.com/inward/record.url?scp=78650274430&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78650274430&partnerID=8YFLogxK
U2 - 10.1038/jid.2010.251
DO - 10.1038/jid.2010.251
M3 - Article
C2 - 20739951
AN - SCOPUS:78650274430
SN - 0022-202X
VL - 131
SP - 67
EP - 73
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 1
ER -